- Home
- SOND vs LSTA Comparison
SOND vs LSTA Comparison
Compare SOND & LSTA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- SOND
- LSTA
- Stock Information
- Founded
- SOND 2014
- LSTA 1980
- Country
- SOND United States
- LSTA United States
- Employees
- SOND N/A
- LSTA 26
- Industry
- SOND Hotels/Resorts
- LSTA Misc Health and Biotechnology Services
- Sector
- SOND Consumer Discretionary
- LSTA Health Care
- Exchange
- SOND Nasdaq
- LSTA Nasdaq
- Market Cap
- SOND 23.2M
- LSTA 22.5M
- IPO Year
- SOND N/A
- LSTA N/A
- Fundamental
- Price
- SOND $3.00
- LSTA $2.72
- Analyst Decision
- SOND
- LSTA Strong Buy
- Analyst Count
- SOND 0
- LSTA 1
- Target Price
- SOND N/A
- LSTA $15.00
- AVG Volume (30 Days)
- SOND 328.4K
- LSTA 23.4K
- Earning Date
- SOND 07-22-2025
- LSTA 08-11-2025
- Dividend Yield
- SOND N/A
- LSTA N/A
- EPS Growth
- SOND N/A
- LSTA N/A
- EPS
- SOND N/A
- LSTA N/A
- Revenue
- SOND $624,458,000.00
- LSTA $1,000,000.00
- Revenue This Year
- SOND $28.50
- LSTA N/A
- Revenue Next Year
- SOND $17.62
- LSTA N/A
- P/E Ratio
- SOND N/A
- LSTA N/A
- Revenue Growth
- SOND 8.32
- LSTA N/A
- 52 Week Low
- SOND $0.88
- LSTA $1.87
- 52 Week High
- SOND $10.50
- LSTA $4.20
- Technical
- Relative Strength Index (RSI)
- SOND 65.52
- LSTA 52.43
- Support Level
- SOND $2.69
- LSTA $2.34
- Resistance Level
- SOND $3.44
- LSTA $3.09
- Average True Range (ATR)
- SOND 0.35
- LSTA 0.25
- MACD
- SOND 0.10
- LSTA 0.01
- Stochastic Oscillator
- SOND 79.64
- LSTA 50.67
About SOND Sonder Holdings Inc.
Sonder Holdings Inc is engaged in providing short and long-term accommodations to travelers in various cities across North America, Europe, and the Middle East. The Sonder units in each apartment-style building and each hotel property are selected, designed, and managed directly by the Company. The Company generates revenues by providing short-term or month-to-month accommodations to its guests. The Company also provides accommodations to travelers through boutique hotels.
About LSTA Lisata Therapeutics Inc.
Lisata Therapeutics Inc is a clinical-stage pharmaceutical company dedicated to the discovery, development, and commercialization of therapies for the treatment of solid tumors and other diseases. Its investigational product, certepetide, is designed to activate a novel uptake pathway that allows co-administered or tethered (i.e., molecularly bound) anti-cancer drugs to target and penetrate solid tumors more effectively. The group has one operating segment, the research and development of its investigational drug product.